Department of Cancer Biology
Life Sciences | Medicine and Health Sciences
ABSTRACT: The Insulin Receptor Substrate (IRS) proteins are cytoplasmic adaptor proteins that function as essential signaling intermediates downstream of activated cell surface receptors, many of which have been implicated in cancer. The IRS proteins do not contain any intrinsic kinase activity, but rather serve as scaffolds to organize signaling complexes and initiate intracellular signaling pathways. As common intermediates of multiple receptors that can influence tumor progression, the IRS proteins are positioned to play a pivotal role in regulating the response of tumor cells to many different microenvironmental stimuli. Limited studies on IRS expression in human tumors and studies on IRS function in human tumor cell lines and in mouse models have provided clues to the potential function of these adaptor proteins in human cancer. A general theme arises from these studies; IRS-1 and IRS-4 are most often associated with tumor growth and proliferation and IRS-2 is most often associated with tumor motility and invasion. In this review, we discuss the mechanisms by which IRS expression and function are regulated and how the IRS proteins contribute to tumor initiation and progression.
Rights and Permissions
© 2009 Mardilovich et al; licensee BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
DOI of Published Version
Cell Commun Signal. 2009 Jun 17;7:14. Link to article on publisher's site
Cell communication and signaling : CCS
Mardilovich K, Pankratz SL, Shaw LM. (2009). Expression and function of the insulin receptor substrate proteins in cancer. Open Access Articles. https://doi.org/10.1186/1478-811X-7-14. Retrieved from https://escholarship.umassmed.edu/oapubs/2111